The Journal of Infectious Diseases · 1997 · 102 citations · 12 references
Life SciencesImmunologyInfectious DiseasesHost-pathogen InteractionsMolecular VirologyVirologyHost-virus InteractionsPattern Recognition ReceptorsReceptor BindingReceptor-ligand InteractionsViral InfectionsViral TropismCoxsackievirus InfectionsReceptor Binding SpecificityReceptor Usage By VirusesReceptor-ligand Binding SpecificityReceptorsSurface Receptor SpecificityViral Receptor UsageVirus-host Receptor Interactions
Coxsackie B viruses interact with two putative cell surface receptor molecules. Experiments with prototype laboratory strains suggest that all 6 coxsackie B serotypes interact with a 46-kDa protein recognized by the monoclonal antibody RmcB, whereas CB1, CB3, and CB5 may also bind to decay accelerating factor. Antireceptor monoclonal antibodies were used to study interactions between low-passage clinical coxsackie B virus isolates and the two receptors. In contrast to observations made with single prototype strains, these data indicate that receptor use by clinical isolates is not strictly related to serotype and that even prototype strains with different passage histories may differ in receptor use. Within a given serotype, variation exists in the capacity of individual virus isolates to bind to specific receptors, and variants with altered receptor specificity may arise during infection in humans and in tissue culture.
12
Jeffrey M. Bergelson, Melvin Chan, Keith R. Solomon et al. · Proceedings of the National Academy of Sciences · 1994 · 344 citations · Full text